SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000882104-13-000044
Filing Date
2013-10-30
Accepted
2013-10-30 16:02:18
Documents
2
Period of Report
2013-10-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pdli-20131030x8xkdoc.htm 8-K 29239
2 CREDIT AGREEMENT pdli-20031030x8kex101.htm EX-10.1 1702582
  Complete submission text file 0000882104-13-000044.txt   1733170
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 131179261
SIC: 2836 Biological Products, (No Diagnostic Substances)